Role of Autotaxin in HCV-associated Hepatocellular Carcinoma
自分泌运动因子在 HCV 相关肝细胞癌中的作用
基本信息
- 批准号:7991071
- 负责人:
- 金额:$ 16.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-14 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBiochemicalCell Culture TechniquesCellsChronic Hepatitis CClinical ResearchCoupledDataDevelopmentDiseaseEmploymentEnzymesEtiologyExhibitsGenesGoalsGuanosine Triphosphate PhosphohydrolasesHepatitis CHepatitis C virusHepatocyteHumanInterventionInvestigationLengthLinkLiverLiver FibrosisLysophospholipidsMalignant NeoplasmsMediatingMessenger RNAModalityModelingMolecularMolecular GeneticsOpen Reading FramesPathogenesisPatientsPlasmaPlayPreventionPrimary carcinoma of the liver cellsProteinsRNA replicationRegulationRepliconReportingRisk FactorsRoleRunningSamplingSerumSignal PathwaySignal TransductionStagingTestingTherapeutic InterventionTissuesTumor TissueViral ProteinsVirus DiseasesVirus Replicationbasecancer cellcancer typehepatoma cellinsightlysophosphatidic acidmRNA Expressionnovelphosphoric diester hydrolasepromoterpublic health relevancepyrophosphataseresearch studyresponserho GTP-Binding Proteinstumortumorigenicviral RNAvirus pathogenesis
项目摘要
DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) infection is the most significant risk factor for the development of hepatocellular carcinoma (HCC), a major liver malignancy and cancer type worldwide. The molecular genetics and signaling pathways associated with HCV-associated HCC pathogenesis remain poorly understood. Our long-term goal is to elucidate the molecular mechanisms underlying progression of chronic HCV to HCC. Autotaxin (ATX), an ectonucleotide pyrophosphatase/phosphodiesterase 2 enzyme and a potent cell stimulating motogen is over-expressed in various malignant tumor tissues and has been implicated to confer the tumorigenic and metastatic potential of a variety of cancer cells. In 2007, two groups provided the first evidence that the serum ATX activity and plasma lysophosphatidic acid (LPA) levels are increased in chronic hepatitis C in association with liver fibrosis, and that ATX and genes related to ATX signaling pathway were upregulated in HCC patients co-infected with HCV. Is this the cause or consequence of HCV infection? And how does aberrant regulation of ATX impact HCV replication and pathogenesis? We postulate that "ATX over-expression and signaling may be an important determinant in the replication and pathogenesis of HCV". Our hypothesis is based on some novel and vital clues linking ATX expression to HCV infection and pathogenesis. In preliminary experiments we observed that ATX mRNA expression is upregulated in the liver tissues of HCV-infected patients and its expression is further enhanced in HCV- associated HCC samples, consistent with the 2007 clinical study. Further, the expression levels of ATX mRNA were upregulated in HCV replicon cells versus replicon cured cells, suggesting a role for HCV in inducing ATX expression. This observation coupled with our data that HCV replicon cells secrete ATX, suggest that the HCV infected liver may potentially contribute to the aberrant expression of ATX in HCV- infected patients and patients with HCV-associated HCC. We found that the ATX promoter was activated and stimulated in HCV replicon cells, thus implicating HCV proteins and host-factors in HCV-infected cells to potentially play a role in aberrant regulation of ATX. Further, over-expression of ATX in HCV RNA bearing human hepatoma cells induced RhoA expression, activated RhoA and stimulated HCV RNA replication. Conversely, blockage of ATX secretion abrogated RhoA induction and ablated HCV RNA replication. We envision that ATX/LPA over-expression during the course of HCV infection may de-regulate mechanisms involved in Rho GTPase signaling thus contributing towards HCV pathogenesis. To test our hypothesis and to extend our findings two independent but complementary specific aims are proposed. In Aim 1 we will investigate the role of viral proteins and host factors in aberrant regulation of ATX expression during HCV infection and pathogenesis. In Aim 2, we propose to address the role of ATX in HCV replication and pathogenesis mechanisms. To investigate these aspects, we propose to employ nontransformed human hepatocytes (HH4 cells) conditionally expressing the full-length HCV ORF (HH4-HCV) as models for the early stage of HCV infection, and C-5B replicon cells which replicate HCV RNA in hepatoma cells to address questions pertaining to the scenario in the HCV infected tumor microenvironment. These objectives will be achieved via multi-prong approach, including cell culture, biochemical and molecular genetics. We envisage that our findings will provide crucial insights into modulation of ATX during HCV infection and further clarify the role of ATX in HCV replication and pathogenesis. These investigations may provide rational target for therapeutic intervention of HCV.
PUBLIC HEALTH RELEVANCE: The proposed studies have the potential to provide crucial insights into regulation and role of autotaxin (ATX), a tumorigenic and metastatic protein, in HCV infection and pathogenesis mechanisms and may likely identify novel modalities for therapeutic intervention of Hepatitis C.
描述(由申请方提供):丙型肝炎病毒(HCV)感染是发生肝细胞癌(HCC)的最重要风险因素,HCC是全球主要的肝脏恶性肿瘤和癌症类型。与HCV相关的HCC发病机制相关的分子遗传学和信号通路仍然知之甚少。我们的长期目标是阐明慢性HCV进展为HCC的分子机制。自分泌运动因子(ATX)是一种外核苷酸焦磷酸酶/磷酸二酯酶2酶和一种强效细胞刺激原,在各种恶性肿瘤组织中过表达,并被认为赋予了多种癌细胞的致瘤性和转移潜力。2007年,两个研究小组首次提供证据表明,慢性丙型肝炎患者血清ATX活性和血浆溶血磷脂酸(LPA)水平升高与肝纤维化相关,并且ATX和ATX信号通路相关基因在合并HCV感染的HCC患者中上调。这是HCV感染的原因还是后果?ATX的异常调节如何影响HCV的复制和发病机制?我们推测“ATX的过度表达和信号转导可能是HCV复制和发病机制的重要决定因素”。我们的假设是基于一些新的和重要的线索连接ATX表达HCV感染和发病机制。在初步实验中,我们观察到ATX mRNA表达在HCV感染患者的肝组织中上调,并且其表达在HCV相关的HCC样品中进一步增强,与2007年的临床研究一致。此外,ATX mRNA的表达水平在HCV复制子细胞中相对于复制子治愈的细胞上调,表明HCV在诱导ATX表达中的作用。这一观察结果与我们的HCV复制子细胞分泌ATX的数据相结合,表明HCV感染的肝脏可能潜在地导致HCV感染的患者和患有HCV相关HCC的患者中ATX的异常表达。我们发现ATX启动子在HCV复制子细胞中被激活和刺激,从而暗示HCV感染细胞中的HCV蛋白和宿主因子可能在ATX的异常调节中发挥作用。此外,在携带HCV RNA的人肝癌细胞中过表达ATX诱导RhoA表达,激活RhoA并刺激HCV RNA复制。相反,ATX分泌的阻断废除RhoA诱导和消融HCV RNA复制。我们设想在HCV感染过程中ATX/LPA的过度表达可能会使Rho GT3信号转导机制失调,从而导致HCV发病。为了检验我们的假设,并扩大我们的研究结果,提出了两个独立但互补的具体目标。在目的1中,我们将研究在HCV感染和发病过程中,病毒蛋白和宿主因子在ATX表达的异常调节中的作用。在目标2中,我们提出了ATX在HCV复制和发病机制中的作用。为了研究这些方面,我们建议采用非转化的人肝细胞(HH 4细胞)有条件地表达全长HCV ORF(HH 4-HCV)作为HCV感染早期阶段的模型,以及在肝癌细胞中复制HCV RNA的C-5 B复制子细胞,以解决与HCV感染肿瘤微环境中的情况有关的问题。这些目标将通过多管齐下的方法来实现,包括细胞培养、生物化学和分子遗传学。我们设想,我们的研究结果将提供重要的见解,在丙型肝炎病毒感染过程中的ATX调制,并进一步阐明ATX在丙型肝炎病毒复制和发病机制中的作用。这些研究为HCV的治疗干预提供了合理的靶点。
公共卫生关系:拟议的研究有可能为自分泌运动因子(ATX)(一种致瘤性和转移性蛋白)在HCV感染和发病机制中的调节和作用提供重要见解,并可能确定丙型肝炎治疗干预的新模式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neerja Kaushik-Basu其他文献
Neerja Kaushik-Basu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neerja Kaushik-Basu', 18)}}的其他基金
Role of Autotaxin in HCV-associated Hepatocellular Carcinoma
自分泌运动因子在 HCV 相关肝细胞癌中的作用
- 批准号:
8089443 - 财政年份:2010
- 资助金额:
$ 16.97万 - 项目类别:
Role of Autotaxin in HCV-associated Hepatocellular Carcinoma
自分泌运动因子在 HCV 相关肝细胞癌中的作用
- 批准号:
8701007 - 财政年份:2010
- 资助金额:
$ 16.97万 - 项目类别:
EFFECTORS AND IINHIBITORS OF SARS VIRUS POLYMERASE
SARS病毒聚合酶的效应物和抑制剂
- 批准号:
7028852 - 财政年份:2005
- 资助金额:
$ 16.97万 - 项目类别:
EFFECTORS AND IINHIBITORS OF SARS VIRUS POLYMERASE
SARS病毒聚合酶的效应物和抑制剂
- 批准号:
6873098 - 财政年份:2005
- 资助金额:
$ 16.97万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 16.97万 - 项目类别:
Continuing Grant
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Operating Grants
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Standard Grant
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
EAGER: Elastic Electronics for Sensing Gut Luminal and Serosal Biochemical Release
EAGER:用于感测肠腔和浆膜生化释放的弹性电子器件
- 批准号:
2334134 - 财政年份:2023
- 资助金额:
$ 16.97万 - 项目类别:
Standard Grant